top of page
News
Qubigen and the University of Melbourne Sign Memorandum of Understanding to Explore Drug Development Collaboration
Qubigen is pleased to announce the signing of a Memorandum of Understanding (MoU) with the University of Melbourne, marking the beginning of a potential strategic collaboration for small molecule drug development.
May 301 min read
191 views
Qubigen Joins the TBXT Challenge to Accelerate Discovery of Lead Candidates for Chordoma
Qubigen is proud to announce its participation in the TBXT Challenge, a global initiative to develop lead drug candidates targeting the...
May 301 min read
186 views
Qubigen CEO Jonathan Hall to Present at BIO 2025 in Boston
Qubigen is thrilled to announce that our CEO, Dr. Jonathan M. M. Hall, will be presenting at the 2025 BIO International Convention in...
May 273 min read
79 views
bottom of page